SEC Form 4 · accession 0001104659-16-131584

Syros Pharmaceuticals, Inc. · SYRS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners

10% Owner

10% Owner

10% Owner

Period of report

Jul 6, 2016

Accepted (ET)

Jul 7, 2016 · 5:41 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001556263

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Jul 6, 2016	C	1,164,486	—	A	1,164,486	I	See Footnote
Common Stock^F1,F3	Jul 6, 2016	C	22,167	—	A	22,167	I	See Footnote
Common Stock^F2	Jul 6, 2016	P	373,847	$12.50	A	1,538,333	I	See Footnote
Common Stock^F3	Jul 6, 2016	P	26,153	$12.50	A	48,320	I	See Footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series B Preferred Stock^F2,F1	—	Jul 6, 2016	C	4,366,825	D	—	—	Common Stock	1,164,486	0	I
Series B Preferred Stock^F3,F1	—	Jul 6, 2016	C	83,129	D	—	—	Common Stock	22,167	0	I

F1The Series B Preferred Stock converted into Common Stock on a 3.75-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
F2The reportable securities are owned directly by Polaris Partners VII, L.P. ("PP VII"). Polaris Management Co. VII, L.L.C. ("PMC VII") is the general partner of PP VII. PMC VII disclaims beneficial ownership of these securities and this report shall not be deemed an admission that PMC VII is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.
F3The reportable securities are owned directly by Polaris Entrepreneurs' Fund VII, L.P. ("PEF VII"). PMC VII is the general partner of PEF VII. PMC VII disclaims beneficial ownership of these securities and this report shall not be deemed an admission that PMC VII is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.